UNH Exec Receives Dividend Equivalents on Restricted Stock Units
UNITEDHEALTH GROUP INC
Subscribe to track UNH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
UNH Exec Receives Dividend Equivalents on RSUs
Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025-12-18 Significance: Low
Insider: McSweeney Erin Title: EVP & Chief People Officer | Relationship: Officer
Transaction: • Type: Grant • Shares: 38.566 • Price: $0.00 • Value: $0 • Owned After: 11,192.638
Key Insight: This is a routine, non-cash acquisition of dividend equivalents on existing restricted stock units (RSUs), not an open-market purchase. It has no market impact.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An executive received a small number of shares as dividend equivalents on existing restricted stock units (RSUs), a routine, non-cash event.
- Market Impact: Neutral. This transaction has no market impact due to its nature and negligible size.
Company Information
| Field | Value |
|---|---|
| Company | UNITEDHEALTH GROUP INC |
| Ticker Symbol | UNH |
| CIK | 0000731766 |
| Industry | Hospital & Medical Service Plans |
Insider Information
| Field | Value |
|---|---|
| Name | McSweeney Erin |
| CIK | 0001645325 |
| Title/Position | EVP & Chief People Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-16 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 38.566 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 11,192.638 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0000% |
| Shares Transacted | 38.566 |
| % of Shares Outstanding | 0.000004% |
| Post-Transaction Ownership | 11,192.638 shares (0.0012% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value is $0, making it immaterial against UnitedHealth Group's market capitalization of $291.55 billion.
- Ownership Concentration: The insider's total holdings of 11,192.638 shares represent a negligible fraction (0.0012%) of the total shares outstanding.
- Dilution Impact: The issuance of 38.566 shares has a zero dilution impact on existing shareholders.
- Transaction Significance: This transaction is considered routine and carries low significance. It is a non-discretionary acquisition tied to dividends on prior awards, not a new investment decision by the insider.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a non-cash, automatic acquisition of dividend equivalents with a total value of $0. It does not signal any change in insider sentiment or company outlook.
Volume & Sentiment
- Expected Volume Impact: None. This is not an open-market transaction and will not affect trading volume.
- Sentiment Indicator: Neutral. The filing is procedural and provides no new information to influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: As noted in the filing's footnote, the shares represent dividend equivalents paid on outstanding restricted stock units. These are subject to the same vesting terms as the underlying RSUs.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
